Conversion Labs Inc (OTCMKTS:CVLB) CEO Justin Schreiber purchased 75,000 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were purchased at an average price of $0.17 per share, with a total value of $12,750.00.
Justin Schreiber also recently made the following trade(s):
- On Thursday, November 7th, Justin Schreiber purchased 49,487 shares of Conversion Labs stock. The shares were purchased at an average price of $0.17 per share, with a total value of $8,412.79.
- On Wednesday, October 30th, Justin Schreiber purchased 74,128 shares of Conversion Labs stock. The shares were purchased at an average price of $0.16 per share, with a total value of $11,860.48.
OTCMKTS:CVLB traded up $0.01 on Monday, hitting $0.17. 212,171 shares of the stock were exchanged, compared to its average volume of 85,037. Conversion Labs Inc has a fifty-two week low of $0.08 and a fifty-two week high of $0.21. The stock has a fifty day moving average of $0.16 and a 200-day moving average of $0.14. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.27 and a current ratio of 0.57.
Separately, ValuEngine upgraded Conversion Labs from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd.
Conversion Labs Company Profile
Conversion Labs, Inc, an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software.
Featured Article: What is the Hang Seng index?
Receive News & Ratings for Conversion Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conversion Labs and related companies with MarketBeat.com's FREE daily email newsletter.